No-moat Clinuvel CUV is suspending early-stage clinical trials evaluating afamelanotide, a synthetic drug already used in its ...

With the cost of education increasing and federal re-election campaigns fired up, find out what new changes to HECS may mean ...

Munger wanted to make a point about what it takes to be successful at investing or anything else in life. He said, “the first ...

Today I’m going to think a bit about step four and beyond: how an investor might find potential investments that are aligned ...

Signs of improvement in continued improvement in core business.

Article Page URL has been copied to clipboard for sharing. A few readers that have emailed me recently seem to follow some ...

In the pursuit of continued earnings growth, Aristocrat is at risk of overpaying for acquisitions in its competitively more ...

Recent election results have sent US markets into a record-high rally however implications remain mixed for the Australian ...

Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar vehicles, ...

Our Fair Value estimate for MinRes is $64 per share or almost 70% higher than current share price levels of around $38. Mark ...

New research reveals undiagnosed cognitive decline can cost retirees tens of thousands of dollars through bad investments or ...

Tesla shares rose roughly 28% this past week on news that Donald Trump was elected to become the next US president. The ...